Press Release – BioMark Continues to Strengthen its Intellectual Property position With New Patent
and Trademark Use in Canada
![biomark diagnostics patent](https://www.biomarkdiagnostics.com/wp-content/uploads/2022/06/biomark-diagnostics-patent.jpg)
BioMark Continues to Strengthen its Intellectual Property position With New Patent and Trademark Use in Canada Vancouver, British Columbia – (June 21st, 2022) – BioMark Diagnostics Inc. (“BioMark” or the “Company”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) an advanced stage liquid biopsy company developing molecular diagnostic tests with a focus on hard to detect and […]